Crinetics Pharmaceuticals shares are trading higher after the company announced it will be acquired by Vertex Pharmaceuticals. HC Wainwright & Co and Baird raised their respective price targets on the stock.

Benzinga Newsdesk www.benzinga.com Positive 90.5%

Neg 0% Neu 0% Pos 90.5%

Comments

No comments yet. Be the first!